NEW YORK, June 18 -- Aclara BioSciences announced today the extension of a services and supply agreement with Stanford University for use in a new proteomics center.
The Mountain View, Calif.-based company will supply the Stanford University Medical Center with access to its eTag assay system technology, custom services, reagents, software, and support. The university will use the system for proteomics studies in the area of autoimmune disease.
Financial details were not disclosed.
Using funding from a seven-year, $14.6 million contract from the National Heart Lung and Blood Institute, Stanford's Center for Clinical Immunology will establish a proteomics center to study autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis.
ACLARA's eTag technology is used in the analysis of genes and proteins.